I agree 3's is on the cards if no solid news over the next month...

I agree 3's is on the cards if no solid news over the next month or so. We need to be realistic about what stage we are at here and keep in mind at 5cents it has already 10 bagged from its lows.

The news flow so far is extremely positive but we have major hurdles to cross before we can get that re-rating >10-20cents we are all hoping for. I.e. some form of combination trial, human trials or formal partnering with a major pharma will see the SP explode (assuming positive results!). At the stage the SP is just a reflection of the potential that this could happen.

IMO the re-rate will happen in 2019 if things go well. I can imagine the SP bouncing around 3-7cents until then and the day traders getting stuck into it. I for one won't be giving them any of my shares and am in PAB til the end.

In saying that I would love it if I'm wrong on the timing and management can negotiate us a deal too good to pass up in 2018. I just can't see it happening for another year or so now based on the information available.